ABSTRACT
We developed an innovative and efficient, feeder-free culture method to genetically modify and expand peripheral blood-derived NK cells with high proliferative capacity, while preserving the responsiveness of their native activating receptors. Activated peripheral blood NK cells were efficiently transduced by a retroviral vector, carrying a second-generation CAR targeting CD19. CAR expression was demonstrated across the different NK-cell subsets. CAR.CD19-NK cells display higher antileukemic activity toward CD19+ cell lines and primary blasts obtained from patients with B-cell precursor ALL compared with unmodified NK cells. In vivo animal model data showed that the antileukemia activity of CAR.CD19-NK cell is superimposable to that of CAR-T cells, with a lower xenograft toxicity profile. These data support the feasibility of generating feeder-free expanded, genetically modified peripheral blood NK cells for effective "off-the-shelf" immuno-gene-therapy, while their innate alloreactivity can be safely harnessed to potentiate allogeneic cell therapy.
Subject(s)
Antigens, CD19/immunology , Cell- and Tissue-Based Therapy/methods , Immunotherapy, Adoptive/methods , Killer Cells, Natural/transplantation , Leukocytes, Mononuclear/immunology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/therapy , Receptors, Chimeric Antigen/immunology , Animals , Apoptosis , Cell Proliferation , Cytotoxicity, Immunologic/immunology , Humans , Killer Cells, Natural/immunology , Mice , Mice, Inbred NOD , Mice, SCID , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Tumor Cells, Cultured , Xenograft Model Antitumor AssaysABSTRACT
BACKGROUND: The social impact of degenerative diseases is steadily increasing, because of the continued rise in the mean age of the active population. Articular cartilage lesions are generally associated with disability and symptoms such as joint pain and reduced function, and remain a challenge for the orthopaedic surgeon. Several non-invasive solution have been proposed, but the results achieved to date are far from being completely satisfactory. Recently, new therapeutic approaches, such as the use of mesenchymal stem cells, have been developed. Among the many sources, the adipose tissue is nowadays considered one of the smartest, due to its abundance and easy access. The aim of this retrospective study is to explore whether patients affected by symptomatic knee osteoarthritis treated with micro-fragmented adipose tissue associated with a chondral shaving procedure experience an improvement in symptoms and function. METHODS: Thirty-eight patients affected by symptomatic knee osteoarthritis were treated in 2015 with an arthroscopic procedure associated with an injection of autologous and micro-fragmented adipose tissue. Micro-fragmented adipose tissue was obtained using a minimal manipulation technique in a closed system. Clinical outcomes were determined at 1, 3, 6, and 12 months follow-up using Knee Injury and Osteoarthritis Outcome Score questionnaire and direct physical examination. Safety of the procedure, recording type and incidence of any adverse event, was also assessed. RESULTS: A steady and statistically significant improvement of all the clinical scores from pre-operative evaluation to 1, 3, 6, and 12 months follow-up was observed, with KOOS sport and quality of life being the most improved scores. On average, 92% of the patients clinically improved and 100% of them were satisfied with the treatment. No adverse events nor relevant complications were recorded. CONCLUSION: The result of the study pointed to micro-fragmented adipose tissue as a safe and beneficial adjuvant in the surgical treatment of degenerative knee chondropathy. The procedure is simple, sustainable, quick, minimally invasive, one-step, and safe. After one year, the results are very satisfactory and promising. A longer follow-up is needed to draw definitive conclusions and enlarge the indications. TRIAL REGISTRATION: Registered at clinicaltrials.gov as NCT03527693 on 27 April 2018 (retrospectively registered).
Subject(s)
Adipose Tissue/transplantation , Arthroscopy/methods , Osteoarthritis, Knee/diagnosis , Osteoarthritis, Knee/therapy , Adult , Female , Humans , Injections, Intra-Articular/methods , Male , Middle Aged , Retrospective Studies , Transplantation, Autologous/methodsABSTRACT
This work reports the results of the theoretical investigation of nonlinear dynamics and spiral wave breakup in a generalized two-variable model of cardiac action potential accounting for thermo-electric coupling and diffusion nonlinearities. As customary in excitable media, the common Q10 and Moore factors are used to describe thermo-electric feedback in a 10° range. Motivated by the porous nature of the cardiac tissue, in this study we also propose a nonlinear Fickian flux formulated by Taylor expanding the voltage dependent diffusion coefficient up to quadratic terms. A fine tuning of the diffusive parameters is performed a priori to match the conduction velocity of the equivalent cable model. The resulting combined effects are then studied by numerically simulating different stimulation protocols on a one-dimensional cable. Model features are compared in terms of action potential morphology, restitution curves, frequency spectra, and spatio-temporal phase differences. Two-dimensional long-run simulations are finally performed to characterize spiral breakup during sustained fibrillation at different thermal states. Temperature and nonlinear diffusion effects are found to impact the repolarization phase of the action potential wave with non-monotone patterns and to increase the propensity of arrhythmogenesis.
Subject(s)
Action Potentials/physiology , Electricity , Models, Cardiovascular , Nonlinear Dynamics , Temperature , Diffusion , Finite Element Analysis , Numerical Analysis, Computer-AssistedABSTRACT
O objetivo deste estudo foi avaliar a viabilidade econômica, por meio da análise conjunta de indicadores financeiros expressos por animal, da terminação em confinamento de novilhos Aberdeen Angus recebendo dietas com diferentes níveis de concentrado (NC): 25, 40, 55 ou 70% (base na matéria seca). Foram consideradas cotações históricas consecutivas dos anos de 2003 a 2014. A análise univariada caracterizou-se por delineamento inteiramente ao acaso, com quatro tratamentos e quatro repetições, procedendo-se à análise de regressão. A análise multivariada consistiu de agrupamento (cluster). Pela análise univariada, houve similaridade para os indicadores financeiros, com médias para margem bruta de R$ 173,21; margem líquida de R$ 163,73; lucro de R$ 110,61; valor presente líquido de R$ 93,31; índice benefício: custo de 1,048; retorno adicional sobre o investimento de 1,17% a.m.; taxa interna de retorno de 2,04% a.m. e payback descontado de 1,36 mês. Pela análise de cluster, o NC de 55% apresentou maior discrepância em relação aos demais níveis, enquanto 40 e 70% foram os mais próximos. A análise conjunta dos indicadores financeiros indicou viabilidade do confinamento de novilhos, independentemente do nível de concentrado.(AU)
The objective of this study was to evaluate the economic viability, through the joint analysis of financial indicators expressed by animal, of the Aberdeen Angus steers feedlot finished fed diets with different levels of concentrate (CL): 25, 40, 55 or 70% (on dry matter basis). Consecutive historical quotes of years 2003 to 2014 were considered. Univariate analysis was characterized by a completely randomized design with four treatments and four replications, proceeding regression analysis. Multivariate analysis consisted of grouping (cluster). The univariate analysis showed similarity to the financial indicators with averages to gross margin of R$ 173.21; net margin of R$ 163.73; income of R$ 110.61; net present value of R$ 93.31; benefit: cost ratio of 1.048; additional return on investment of 1.17% per month; internal rate of return of 2.04% per month and discounted payback of 1.36 months. By cluster analysis, 55% CL presented greater discrepancy in relation to other levels, while 40 and 70% were the nearest. The analysis of the financial indicators indicated feasibility of feedlot steers, regardless of the concentrate level.(AU)
Subject(s)
Animals , Cattle , Cost-Benefit Analysis , Diet/veterinary , Decision Making , EfficiencyABSTRACT
O objetivo deste estudo foi avaliar a viabilidade econômica, por meio da análise conjunta de indicadores financeiros expressos por animal, da terminação em confinamento de novilhos Aberdeen Angus recebendo dietas com diferentes níveis de concentrado (NC): 25, 40, 55 ou 70% (base na matéria seca). Foram consideradas cotações históricas consecutivas dos anos de 2003 a 2014. A análise univariada caracterizou-se por delineamento inteiramente ao acaso, com quatro tratamentos e quatro repetições, procedendo-se à análise de regressão. A análise multivariada consistiu de agrupamento (cluster). Pela análise univariada, houve similaridade para os indicadores financeiros, com médias para margem bruta de R$ 173,21; margem líquida de R$ 163,73; lucro de R$ 110,61; valor presente líquido de R$ 93,31; índice benefício: custo de 1,048; retorno adicional sobre o investimento de 1,17% a.m.; taxa interna de retorno de 2,04% a.m. e payback descontado de 1,36 mês. Pela análise de cluster, o NC de 55% apresentou maior discrepância em relação aos demais níveis, enquanto 40 e 70% foram os mais próximos. A análise conjunta dos indicadores financeiros indicou viabilidade do confinamento de novilhos, independentemente do nível de concentrado.
The objective of this study was to evaluate the economic viability, through the joint analysis of financial indicators expressed by animal, of the Aberdeen Angus steers feedlot finished fed diets with different levels of concentrate (CL): 25, 40, 55 or 70% (on dry matter basis). Consecutive historical quotes of years 2003 to 2014 were considered. Univariate analysis was characterized by a completely randomized design with four treatments and four replications, proceeding regression analysis. Multivariate analysis consisted of grouping (cluster). The univariate analysis showed similarity to the financial indicators with averages to gross margin of R$ 173.21; net margin of R$ 163.73; income of R$ 110.61; net present value of R$ 93.31; benefit: cost ratio of 1.048; additional return on investment of 1.17% per month; internal rate of return of 2.04% per month and discounted payback of 1.36 months. By cluster analysis, 55% CL presented greater discrepancy in relation to other levels, while 40 and 70% were the nearest. The analysis of the financial indicators indicated feasibility of feedlot steers, regardless of the concentrate level.
Subject(s)
Animals , Cattle , Cost-Benefit Analysis , Diet/veterinary , Efficiency , Decision MakingABSTRACT
The spin features of surface resonance bands in single layer Bi on Ge(1 1 1) are studied by means of spin- and angle-resolved photoemission spectroscopy and inverse photoemission spectroscopy. We characterize the occupied and empty surface states of Ge(1 1 1) and show that the deposition of one monolayer of Bi on Ge(1 1 1) leads to the appearance of spin-polarized surface resonance bands. In particular, the C 3v symmetry, which Bi adatoms adopt on Ge(1 1 1), allows for the presence of Rashba-like occupied and unoccupied electronic states around the [Formula: see text] point of the Bi surface Brillouin zone with a giant spin-orbit constant [Formula: see text] eV · Å.
ABSTRACT
BACKGROUND: We hypothesised that psychological support would have a significant improvement on the mental and physical recovery of patients undergoing primary total hip or knee arthroplasty. MATERIALS AND METHODS: 200 patients were consecutively alternately assigned (1:1) to receive routine care (control group) or, in addition, psychological support from a professional psychologist (experimental group). The psychological support was provided at the pre-operative visit, during the hospitalisation period and at the rehabilitation centre. RESULTS: Upon discharge, based on the 'Hospital Anxiety and Depression Scale, a state of anxiety was observed in 12.8 % and 78.9 % of the patients in the experimental and in the control group, respectively (p < 0.0001). A state of depression was observed in 12.8 % and 73.7 % of the patients in the experimental and in the control group, respectively (p < 0.0001). With regard to the 'Physical Component Scale' of the SF-36 questionnaire, a similar temporal trend of values was observed in the two study groups, significantly increasing over time in both groups, taking into consideration both the joint population and the two hip and knee populations separately (p < 0.0001). With regard to the 'Mental Component Scale' of the SF-36 questionnaire, in both the joint population and the two hip and knee populations separately, an exact opposite temporal trend was observed in the experimental group compared to the control group (p < 0.0001), with generally higher scores in the experimental group (p < 0.0001). In patients with hip arthroplasty, the average time to reach the physiotherapy objective (i.e., the patient ability to walk 50 metres independently and to climb 10 steps) was 6.7 ± 1.8 days (range 4-12) in the experimental group and 7.9 ± 2.2 days (range 0-13) in the control group (p = 0.0015). CONCLUSIONS: In summary, there was a lower incidence of anxiety and depression and better mental well-being in the group of patients who received the psychological support. Within the hip arthroplasty group, the patients who received the psychological support reached the physiotherapy objective 1.2 days earlier than the patients in the control group (p = 0.0015). LEVEL OF EVIDENCE: Level 3, Non-randomized prospective controlled cohort.
Subject(s)
Arthroplasty, Replacement, Hip/psychology , Arthroplasty, Replacement, Knee/psychology , Social Support , Aged , Anxiety/epidemiology , Anxiety/prevention & control , Depression/epidemiology , Depression/prevention & control , Female , Humans , Incidence , Male , Middle Aged , Prospective Studies , Psychiatric Status Rating Scales , Treatment OutcomeABSTRACT
Cerebral cavernous malformations (CCMs) are a diffuse cerebrovascular disease affecting approximately 0.5% of the population. A CCM is characterized by abnormally enlarged and leaky capillaries arranged in mulberry-like structures with no clear flow pattern. The lesion might predispose to seizures, focal neurological deficits or fatal intracerebral hemorrhage. However, a CCM can also remain neurologically silent. It might either occur sporadically or as an inherited disorder with incomplete penetrance and variable expressivity. Due to advances in imaging techniques, the incidence of CCM diagnoses are increasing, and the patient must be managed on a multidisciplinary basis: genetic counselling, treatment if needed, and follow-up. Advances have been made using radiological and pathological correlates of CCM lesions adding to the accumulated knowledge of this disease, although management of these patients is very variable among centers. This review is aimed at providing an update in genetic and molecular insights of this condition. Included are implications for genetic counselling, and possible approaches to prevention and treatment that derive from the understanding of pathogenetic mechanisms.
Subject(s)
Brain , Central Nervous System/pathology , Hemangioma, Cavernous, Central Nervous System , Microtubule-Associated Proteins , Proto-Oncogene Proteins , Brain/metabolism , Brain/pathology , Central Nervous System/metabolism , Cerebral Hemorrhage/genetics , Cerebral Hemorrhage/pathology , Genetic Counseling , Hemangioma, Cavernous, Central Nervous System/diagnosis , Hemangioma, Cavernous, Central Nervous System/genetics , Hemangioma, Cavernous, Central Nervous System/physiopathology , Hemangioma, Cavernous, Central Nervous System/therapy , Humans , KRIT1 Protein , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Molecular Targeted Therapy , Mutation , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Seizures/genetics , Seizures/pathologyABSTRACT
Despite central nervous system (CNS) prophylactic programs limit leptomeningeal involvement in acute lymphoblastic leukemia (ALL), it can still occur in a restricted percentage of cases. The exact risk rate remains still unknown, and several factors are associated with an increased probability to develop CNS involvement. Among them, Philadelphia (Ph)-positive genotype seems to play a relevant role. Recently, a flow cytometric assay to detect BCR-ABL protein has been developed, but little is known about its possible employment in leptomeningeal disease. Here, we show the miniaturized application of the original assay for BCR-ABL oncoprotein detection in cerebrospinal fluid (CSF) samples.
Subject(s)
Flow Cytometry/methods , Fusion Proteins, bcr-abl/cerebrospinal fluid , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis , Meningeal Neoplasms/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Diagnosis, Differential , Fusion Proteins, bcr-abl/genetics , Humans , Immunoassay , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/cerebrospinal fluid , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Meningeal Neoplasms/cerebrospinal fluid , Meningeal Neoplasms/complications , Meningeal Neoplasms/genetics , Philadelphia Chromosome , Polymerase Chain Reaction , Precursor Cell Lymphoblastic Leukemia-Lymphoma/cerebrospinal fluid , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Sensitivity and SpecificityABSTRACT
Recently the definition, the pathophysiology and even the clinical utility of metabolic syndrome (MS) have been discussed. The risk induced by each component of the metabolic syndrome is higher than the risk induced by MS alone. MS alone is, in fact, a weaker predictor of cardiovascular disease than diabetes. New criteria to define the metabolic syndrome have been proposed, as adipokines, CRP and PAI-1. IGFBP-1 is related to hyperinsulinemia/insulin resistance and to the risk of diabetes and fatal ischemic heart disease development. IGF/IGFBP system could be a link between insulin resistance and cardiovascular disease. RBP-4 can attenuate insulin signalling in skeletal muscle and induce hepatic gluconeogenesis. The belief that insulin-resistance is the main cause of MS could change in favour of the adipose tissue dysfunction. The most common cause of a reduced capacity of the adipose tissue to store fats is the increased dietary intake, also present in lipodistrophy, type 1 diabetes mellitus and polycystic ovarian syndrome. The adipose tissue production of adipokines and cytokines (such as IL-6, TNF-alpha and TGF-beta) and the excessive lipid flux towards muscles, heart and liver (Ectopic fat storage syndrome) contribute to the MS genesis and to an increased cardiovascular risk. The comprehension of adipose tissue dysfunction mechanisms offers new possibilities of prevention and therapy.
Subject(s)
Adipose Tissue/metabolism , Insulin Resistance , Metabolic Syndrome , Adiponectin/physiology , Adipose Tissue/physiopathology , C-Reactive Protein/physiology , Humans , Insulin-Like Growth Factor Binding Proteins/physiology , Interleukin-6/physiology , Leptin/physiology , Metabolic Syndrome/diagnosis , Metabolic Syndrome/etiology , Metabolic Syndrome/metabolism , Plasminogen Activator Inhibitor 1/physiology , Retinoblastoma Protein/physiology , Terminology as TopicABSTRACT
Diabetic subjects have a higher infective risk than healthy people, with more frequent and severe infections. This predisposition to infections is determined by hyperglycemia, microangiopathy and altered immune system. In particular, there is a polymorphonuclear leukocytes disfunction including chemotaxis, phagocytosis, bacterial killing and cellular activation by infective stimulus. These alterations are due to abnormal properties of polymorphonuclear leukocytes (PMN) in diabetic patients. Several parameters like phagocytosis of bacterial cells, chemiluminescence during oxidative burst and cell membrane deformability are related to glycaemia and glycated hemoglobin. Recent acquisitions show an altered integrin pattern on diabetics PMN, at baseline and after in vitro stimulation with soluble stimulus like fMLP or PMA. This could influence the interactions between PMN and endothelial cells and the diapedesis. Receptorial alterations on PMN surface may be ascribed to the abnormalities of the cytoscheleton, of the endocytosis and of the transduction mechanism, due to hyperglycemia.
Subject(s)
Diabetes Mellitus/immunology , Neutrophils/physiology , Diabetes Mellitus/blood , Hemorheology , Humans , Hyperglycemia/blood , Hyperglycemia/immunology , Immunity, CellularABSTRACT
New evidence about diabetic microangiopathy has enabled us to identify an integrated pathogenesis of diabetic complications, including classic metabolic pathways induced by hyperglycaemia, insulin-resistance, hyperinsulinaemia, hormonal alterations and growth factors. Oxidative stress is the most important cause of endothelial damage inducing leukocyte adhesion, altered coagulation and inflammation. Adhesion molecules are a marker of endothelial damage and a potential therapeutic target. Changes in the extracellular matrix induced by TGFbeta1 and lower levels of eparan-sulfate, increased thickness of basement membranes and loss of pericytes are early events of diabetic retinopathy and diabetic nephropathy. Capillary rarefaction produced by genetic factors or by fetal undernourishment contributes to the beginning of insulin-resistance and hypertension. Psychophysical tests, electroretinogram and evoked potentials show retinal functional alterations; fundoscopy and retinal fluorescein angiography show retinal anatomic alterations. The diagnosis of diabetic neuropathy is based not only on traditional neurological examination and electroneurograms, but also on neurothesiometry for sensory testing. Medical treatment of diabetic microangiopathy is based on control of glycaemia, lipemia and blood pressure using glytazones, ACE-inhibitors, angiotensin II receptor antagonists and statins. New knowledgeabout microangiopathy pathogenesis suggests potential drugs for its therapy (ruboxistaurin, AGE-inhibitors, angiopoietin-1 and anti-VEGF, etc.), not yet on sale.
Subject(s)
Diabetic Angiopathies , Antihypertensive Agents/therapeutic use , Antioxidants/therapeutic use , Cell Adhesion Molecules/antagonists & inhibitors , Cell Adhesion Molecules/physiology , Diabetes Mellitus/blood , Diabetes Mellitus/drug therapy , Diabetes Mellitus/physiopathology , Diabetic Angiopathies/diagnosis , Diabetic Angiopathies/drug therapy , Diabetic Angiopathies/etiology , Diabetic Angiopathies/physiopathology , Diabetic Angiopathies/prevention & control , Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/diet therapy , Diabetic Nephropathies/physiopathology , Diagnostic Techniques, Ophthalmological , Drugs, Investigational/therapeutic use , Endothelium, Vascular/physiopathology , Glycation End Products, Advanced/metabolism , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypoglycemic Agents/therapeutic use , Inflammation/physiopathology , Insulin Resistance , Intercellular Signaling Peptides and Proteins/metabolism , Oxidative Stress , Polymers/metabolism , Protein Kinase C/metabolism , Thrombophilia/etiologyABSTRACT
Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) has a dismal prognosis. We prospectively evaluated minimal residual disease (MRD) by measuring BCR/ ABL levels with a quantitative real-time PCR procedure after induction and after consolidation in 45 adults with Ph+ ALL who obtained complete hematological remission after a high-dose daunorubicin induction schedule. At diagnosis, the mean BCR-ABL/GUS ratio was 1.55 +/- 1.78. A total of 42 patients evaluable for outcome analysis were operationally divided into two MRD groups: good molecular responders (GMRs; n = 28) with > 2 log reduction of residual disease after induction and > 3 log reduction after consolidation therapy, and poor molecular responders (PMRs; n = 14) who, despite complete hematological remission, had a higher MRD at both time points. In GMR, the actuarial probability of relapse-free, disease-free and overall survival at two years was 38, 27 and 48%, respectively, as compared to 0, 0 and 0% in PMR (P = 0.0035, 0.0076 and 0.0026, respectively). Salvage therapy induced a second sustained complete hematological remission in three GMR patients, but in no PMR patient. Our data indicate that, as already shown in children, adult Ph+ ALL patients have a heterogeneous sensitivity to treatment, and that early quantification of residual disease is a prognostic parameter in this disease.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Fusion Proteins, bcr-abl/genetics , Philadelphia Chromosome , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Adolescent , Adult , Antibiotics, Antineoplastic/therapeutic use , Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Asparaginase/therapeutic use , Cytarabine/therapeutic use , Daunorubicin/therapeutic use , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm, Residual/drug therapy , Neoplasm, Residual/genetics , Neoplasm, Residual/mortality , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Predictive Value of Tests , Prognosis , Reverse Transcriptase Polymerase Chain Reaction , Vincristine/therapeutic useABSTRACT
Within 285 adult acute lymphoblastic leukemias (ALL) included in the multicenter GIMEMA 0496 trial and prospectively studied by conventional cytogenetics, 18 cases (6%) with long arm deletion of chromosome 6 (6q) were identified. These cases were divided into: (i) del(6q) only (n = 6); (ii) del(6q) plus other numerical and/or structural abnormalities (n = 8); (iii) del(6q) and other 'specific' translocations (n = 4). The biologic and clinical features of the patients carrying this anomaly, as well as their outcome, were compared with those of 267 patients without del(6q). A T cell phenotype was more frequently associated with del(6q) cases in general (P = 0.001) and particularly with cases presenting del(6q) as the isolated abnormality (P = 0.0027). No significant difference with respect to multidrug resistance (MDR)/P glycoprotein expression was observed between the two groups of patients (21% vs 28% of MDR-positive cases, respectively). A BCR-ABL fusion transcript was less frequently detected in cases with del(6q) (11%) compared with those without the anomaly (29%). p15 and p16 deletions were identified by Southern blot analysis in 21% of cases with del(6q) and in 26% of cases without del(6q). In this latter group, a T cell phenotype was less frequently associated with p15 and/or p16 deletion than in the group carrying del(6q) (36% vs 100% of cases, P = 0.011). Overall, patients with ALL and del(6q) had a high complete remission (CR) rate (83%); however, they had a lower 18 month event-free survival (31% vs 41%) and a higher relapse rate (70% vs 37%, P = 0.02) compared with patients without del(6q). To date, this is the largest series of adult ALL cases reported with del(6q) homogeneously treated, which have also been prospectively studied for MDR expression and for the detection of known fusion genes. This anomaly, as an isolated change, identifies a subset of cases with hyperleukocytosis (median WBC count 52 x 10(9)/l) and a strict correlation with a T cell phenotype. Overall, del(6q) seems to be associated with an unfavorable clinical outcome, although this finding will need to be confirmed by extended FISH analysis.
Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 6 , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Adult , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Humans , Karyotyping , Phenotype , Polymerase Chain Reaction , Precursor Cell Lymphoblastic Leukemia-Lymphoma/physiopathology , PrognosisABSTRACT
Secondary acute lymphoblastic leukemia (sALL) is an uncommon condition and sALL with L3 morphology is still less frequent. Here, we compare the characteristics of available cases of L3 sALL (16 patients, including 12 previously published cases and 4 personal cases) to those of de novo L3 ALL and of non L3 sALL. Two patients with L3 sALL obtained a CR after aggressive treatment of their leukemia. Compared with 24 patients from the literature with de novo L3 ALL, L3 sALL patients were characterized by an older age (median 46 vs. 29.5 years, p = 0.0003) and by a poor prognosis (complete responses: 2/16 vs. 19/24, p = 0.0001, median survival: 0.46 month vs. undetermined, p < 0.0001). In comparison with 19 patients from the literature with non L3 sALL, L3 sALL patients were characterized by a high Male/Female ratio (14/2 vs. 8/11, p = 0.01), a frequent history of Hodgkin's disease (12/16 vs. 7/19, p = 0.04) and, again, by a poor prognosis (complete responses: 2/16 vs. 13/18, p = 0.0001, median survival 0.46 vs. 13 months, p = 0.001). In conclusion, though based on a small group of heterogeneously treated patients, some characteristics of L3 sALL, seem to emerge, compared both with de novo L3 ALL and with non L3 sALL, the most prominent being its extremely poor prognosis.
Subject(s)
Burkitt Lymphoma/pathology , Neoplasms, Second Primary/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Adult , Aged , Female , Humans , Male , Middle Aged , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Survival RateABSTRACT
The objective of the study was to evaluate the incidence, characteristics, treatment and outcome of acute megakaryoblastic leukemia (AMeL) in patients enrolled in GIMEMA trials. Between 1982 and 1999, 3603 new consecutive cases of AML aged over 15 years were admitted to GIMEMA trials. Of them, 24 were AMeL. The incidence of AMeL among AML patients enrolled in GIMEMA trials was 0.6% (24/3603). Diagnosis was based on morphological criteria. Out of 11 cytogenetic studies performed two presented chromosome 3 abnormalities. Twelve patients (50%) reached a CR, five (21%) died in induction and seven (27%) were unresponsive. The median duration of CR was 35 weeks (range 10-441). Seven patients underwent transplantation procedures (1 BMT, 4 aBMT, 2 aPBSCT). Four patients died in CR due to chemotherapy-related complications. Comparing the CR rate between AMeL and the other cases of AML enrolled in GIMEMA trials, no differences were observed. These results were mirrored for different age groups. The median survival was 40 weeks. At present, after a follow-up of a minimum of 2 years, only two patients are alive in CR, all the others having died. A 5-year Kaplan-Meier curve shows a disease-free survival of 17% and an actuarial overall survival of 10%. AMeL is a rare form of AML. The CR duration and the overall survival in this group of patients are very poor, even if similar to those observed in other AML. Furthermore, a high number of deaths in CR were observed. On the basis of these data, a specific therapeutic approach, possibly with innovative treatments, should be evaluated.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow Transplantation , Leukemia, Megakaryoblastic, Acute/therapy , Adolescent , Adult , Aged , Child , Combined Modality Therapy , Cytogenetic Analysis , Female , Humans , Immunophenotyping , Leukemia, Megakaryoblastic, Acute/mortality , Leukemia, Megakaryoblastic, Acute/pathology , Middle Aged , Remission Induction , Survival Rate , Treatment OutcomeABSTRACT
A 47-year-old male, treated 7 years earlier for Hodgkin's disease (HD), was admitted with persistent fever, liver enlargement, and increased cholestasis parameters. He developed acute bone marrow failure and progressive worsening of his clinical condition and cholestasis markers without showing evidence of HD recurrence or second malignancy. High-dose intravenous pulse methylprednisolone therapy was given, after which resolution of pyrexia and progressive improvement in performance status and in hematological counts and cholestasis parameters were observed. During this phase, a bone biopsy showed HD marrow infiltration. This clinical course may reflect tumor cytokine-induced phenomena, significantly affected by high-dose steroids.
ABSTRACT
Two novel IL2-dependent cell lines, DERL-2 and DERL-7, were established from a patient with hepatosplenic gammadelta T cell lymphoma. This patient presented, at diagnosis, two discrete populations of CD56+ cells, one TCRgammadelta+, the second lacking T cell-restricted antigens. The cell lines derived displayed features corresponding to the two cellular components of the disease: DERL-2 was CD56+/CD3+/TcRgammadelta+ while DERL-7 was CD56+/CD3-/TcRgammadelta-. Along with CD56, the two cell lines shared the expression of CD7, CD2, CD158b and CD117. Karyotype analysis showed that both cell lines were near-diploid, with iso-7q and loss of one chromosome 10. In addition, DERL-2 showed 5q+ in all metaphases analyzed, while DERL-7 revealed loss of one chromosome 4. Genotypically, both cell lines shared the same STR pattern at nine loci and demonstrated an identical rearranged pattern of the T cell receptor genes beta, gamma and delta, with respect to the original tumor cells. These data indicated that both cell lines and the original neoplastic populations were T cell-derived and arose from a common ancestor. Among a large panel of cytokines tested, only SCF was able to substitute IL2 in supporting cell proliferation. Moreover, SCF and IL2 acted synergistically, dramatically enhancing cell growth. These cell lines may represent a model to further analyze the overlap area between T and NK cell malignancies, and may provide new information about the synergistic action of IL2 and SCF on normal and neoplastic T/NK cells.
Subject(s)
Lymphoma, Non-Hodgkin/immunology , Lymphoma, Non-Hodgkin/pathology , Tumor Cells, Cultured/cytology , Adult , CD3 Complex/analysis , CD56 Antigen/analysis , Cell Division/drug effects , Cytogenetic Analysis , Drug Synergism , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor/genetics , Genotype , Humans , Immunophenotyping , Interleukin-2/pharmacology , Male , Receptors, Antigen, T-Cell, gamma-delta/analysis , Receptors, Antigen, T-Cell, gamma-delta/genetics , Stem Cell Factor/pharmacologySubject(s)
Antigens, CD7 , Leukemia-Lymphoma, Adult T-Cell/pathology , Humans , Leukemia, Myelomonocytic, Acute/immunology , Leukemia, Myelomonocytic, Acute/pathology , Leukemia-Lymphoma, Adult T-Cell/immunology , Leukemic Infiltration , Male , Middle Aged , Skin/pathology , Stem Cells/immunology , Stem Cells/pathologyABSTRACT
BACKGROUND AND STUDY AIMS: Ingestion of foreign bodies is a common occurrence. Few papers in the literature report experience and outcome at tertiary centers. The aim of this paper is to report the management and the outcomes in 414 patients admitted for suspected ingestion of foreign body between May 1995 and December 1999. METHODS: A plain radiographic film of the neck, chest or abdomen was obtained in the case of radiopaque objects, and in order to rule out suspected perforation: in such cases a computed tomography (CT) study was also performed. All patients were asked to give their informed consent, which was refused by three patients. Anesthesia was always used, either conscious sedation (86.8 %), or general anesthesia in the case of poor patient tolerance (13.2 %). All patients underwent an endoscopic procedure within six hours of admission. A flexible scope was used in all patients and a wide range of endoscopic devices was employed. RESULTS: Foreign bodies were found in 64.5 % of our patients. Almost all were found in the esophagus. The types of foreign body were very different, but they were chiefly food boluses, bones or cartilages, dental prostheses or fish bones. In three patients (1.1 %) it was impossible to endoscopically remove the foreign body, which was located in the cervical esophagus: all these three patients required surgery. No complications relating to the endoscopic procedure were observed, but 30.7 % of patients had an underlying esophageal disease, such as a stricture. Only eight patients required a second endoscopic procedure, performed by a more experienced endoscopist. CONCLUSION: Foreign body ingestion represents a frequent reason for emergency endoscopy. The endoscopic procedure is a successful technique which allows the removal of the foreign bodies in almost all cases without significant complications. Surgery is rarely required.